COM:MEDIGENE
Medigene AG
- Stock
0.70
−55.04%
−0.85
Last Close
1.55
31/03 15:36
Market Cap
33.01M
Beta: -
Volume Today
158.72K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 3.73M - | 5.53M 48.42% | 7.26M 31.28% | 7.79M 7.37% | 7.51M 3.64% | 3.65M 51.42% | 1 - | ||||
average payables | 1.60M - | 1.57M 2.03% | 1.16M 25.87% | 849K 27.03% | 1.04M 22.67% | 1.37M 31.11% | 903K 33.87% | 465.50K 48.45% | 566K 21.59% | 487K 13.96% | |
average receivables | 1.55M - | 1.25M 19.38% | 969K 22.36% | 1.44M 48.30% | 1.24M 13.50% | 393.50K 68.34% | 2.20M - | ||||
book value per share | 4.02 - | 5.35 33.22% | 3.94 26.43% | 4.01 1.74% | 4.54 13.25% | 3.33 26.60% | 2.16 35.04% | 1.82 15.68% | 1.51 17.38% | 0.86 43.11% | |
capex per share | -0.07 - | -0.08 10.51% | -0.09 9.30% | -0.07 15.77% | -0.04 41.11% | -0.06 35.72% | -0.02 66.11% | -0.01 74.17% | -0.04 705.60% | -0.03 34.06% | |
capex to depreciation | -1.08 - | -1.41 30.53% | -2.04 44.94% | -1.23 39.46% | -0.65 47.75% | -0.60 6.67% | -0.07 87.58% | -0.04 51.24% | -0.05 26.38% | -0.45 884.88% | |
capex to operating cash flow | 0.10 - | 0.13 25.60% | 0.46 266.13% | 0.08 83.64% | 0.10 33.28% | 0.09 13.03% | 0.02 77.54% | 0.01 40.47% | -0.08 823.40% | 0.04 152.23% | |
capex to revenue | -0.06 - | -0.20 207.99% | -0.18 9.40% | -0.14 22.20% | -0.13 4.89% | -0.13 2.71% | -0.06 58.81% | -0.01 78.40% | -0.03 169.75% | -0.11 241.46% | |
cash per share | 1.23 - | 2.78 126.82% | 2.64 5.18% | 2.41 8.80% | 2.17 9.72% | 2.23 2.51% | 1.22 45.08% | 0.91 25.36% | 1.35 48.21% | 0.68 49.81% | |
days of inventory on hand | 770.94 - | 2.20K 185.61% | 2.05K 7.00% | 1.74K 15.07% | 3.14K 80.40% | 0.00 - | |||||
days payables outstanding | 312.33 - | 448.06 43.46% | 253.31 43.46% | 163.25 35.55% | 583.83 257.63% | 1.31K 124.12% | 122.33 90.65% | 133.65 9.26% | 116.70 12.69% | 40.65 65.17% | |
days sales outstanding | 45.89 - | 40.91 10.86% | 43.99 7.54% | 54.52 23.93% | 37.05 32.05% | 62.61 - | |||||
debt to assets | 0.15 - | 0.01 95.59% | 0.02 179.06% | 0.03 66.68% | 0.01 61.72% | 0.05 296.23% | 0.07 49.15% | 0.07 1.86% | 0.07 6.56% | 0.09 29.00% | |
debt to equity | 0.22 - | 0.01 96.17% | 0.03 214.41% | 0.04 52.33% | 0.01 64.46% | 0.06 338.41% | 0.10 57.14% | 0.09 7.40% | 0.10 12.07% | 0.14 39.16% | |
dividend yield | |||||||||||
earnings yield | -0.13 - | -0.09 29.80% | -0.04 55.03% | -0.05 20.63% | -0.09 87.17% | -0.20 125.11% | -0.33 64.36% | -0.14 57.52% | -0.17 18.35% | -0.42 148.28% | |
enterprise value | 41.08M - | 138.20M 236.40% | 224.85M 62.70% | 257.14M 14.36% | 162.98M 36.62% | 68.61M 57.90% | 61.58M 10.24% | 51.98M 15.59% | 31.12M 40.13% | 33.08M 6.32% | |
enterprise value over ebitda | -12.45 - | -14.58 17.15% | -19.05 30.66% | -24.40 28.09% | -10.66 56.30% | -4.01 62.36% | -2.86 28.64% | -8.01 179.62% | 2.37 129.58% | -2.20 192.95% | |
ev to operating cash flow | -4.69 - | -13.03 177.75% | -59.83 359.13% | -12.33 79.39% | -16.07 30.30% | -4.18 74.00% | -2.48 40.53% | -4.83 94.54% | 2.60 153.76% | -2.19 184.22% | |
ev to sales | 2.98 - | 20.30 581.11% | 23.06 13.62% | 22.61 1.99% | 21.02 7.02% | 6.45 69.30% | 7.04 9.07% | 4.97 29.42% | 1.00 79.95% | 5.48 450.57% | |
free cash flow per share | -0.79 - | -0.71 9.97% | -0.27 61.31% | -1.04 279.47% | -0.47 54.78% | -0.73 54.21% | -1.03 41.55% | -0.44 56.95% | 0.45 200.83% | -0.64 243.89% | |
free cash flow yield | -0.21 - | -0.08 61.47% | -0.02 71.71% | -0.08 244.98% | -0.06 25.83% | -0.18 207.64% | -0.29 60.85% | -0.15 47.11% | 0.22 243.01% | -0.41 283.96% | |
graham net net | -0.31 - | 1.61 627.65% | 1.22 24.44% | 1.45 18.63% | 1.41 2.17% | 1.11 21.45% | 0.34 69.09% | 0.32 7.98% | 0.76 139.25% | 0.28 63.39% | |
graham number | 6.53 - | 9.65 47.83% | 6.49 32.73% | 7.54 16.19% | 8.58 13.68% | 7.81 8.99% | 7.57 3.07% | 4.08 46.01% | 3.39 16.97% | 3.56 5.11% | |
income quality | 1.48 - | 0.79 46.56% | 0.39 51.15% | 1.61 316.77% | 0.60 62.98% | 0.82 38.24% | 0.87 5.84% | 1.05 19.84% | -1.28 222.16% | 0.93 173.15% | |
intangibles to total assets | 0.54 - | 0.31 41.57% | 0.32 1.78% | 0.32 1.27% | 0.28 13.78% | 0.33 16.95% | 0.42 29.45% | 0.51 19.67% | 0.19 62.75% | 0 100% | |
interest coverage | -1.60 - | -3.51 119.28% | -10.06 186.73% | -11.81 17.39% | -122.09 934.05% | -44.80 63.30% | -54.52 21.68% | -27.43 49.68% | -13.22 51.79% | -30.31 129.21% | |
interest debt per share | 1.02 - | 0.22 78.20% | 0.17 23.98% | 0.21 25.67% | 0.07 66.87% | 0.22 219.63% | 0.23 1.50% | 0.18 21.39% | 0.18 0.07% | 0.14 20.32% | |
inventory turnover | 0.47 - | 0.17 64.99% | 0.18 7.52% | 0.21 17.75% | 0.12 44.57% | 3.05M - | |||||
invested capital | 0.22 - | 0.01 96.17% | 0.03 214.41% | 0.04 52.33% | 0.01 64.46% | 0.06 338.41% | 0.10 57.14% | 0.09 7.40% | 0.10 12.07% | 0.14 39.16% | |
market cap | 45.46M - | 146.22M 221.63% | 237.44M 62.39% | 281.45M 18.54% | 188.88M 32.89% | 98.24M 47.99% | 86.46M 11.99% | 70.37M 18.61% | 49.62M 29.49% | 38.81M 21.78% | |
net current asset value | 2.45M - | 36.36M 1,381.54% | 30.85M 15.15% | 37.57M 21.79% | 40.03M 6.54% | 30.34M 24.22% | 11.10M 63.42% | 9.51M 14.31% | 22.60M 137.66% | 7.49M 66.87% | |
net debt to ebitda | 1.33 - | 0.85 36.26% | 1.07 26.12% | 2.31 116.34% | 1.69 26.57% | 1.73 2.32% | 1.16 33.25% | 2.83 144.91% | -1.41 149.69% | 0.38 127.05% | |
net income per share | -0.47 - | -0.77 64.03% | -0.48 38.49% | -0.63 32.70% | -0.72 14.10% | -0.81 12.84% | -1.18 44.64% | -0.41 65.43% | -0.34 16.56% | -0.66 94.20% | |
operating cash flow per share | -0.72 - | -0.63 12.01% | -0.19 70.15% | -0.97 414.84% | -0.43 55.81% | -0.67 56.05% | -1.01 50.91% | -0.44 56.61% | 0.49 211.36% | -0.62 226.24% | |
payables turnover | 1.17 - | 0.81 30.29% | 1.44 76.88% | 2.24 55.17% | 0.63 72.04% | 0.28 55.38% | 2.98 969.66% | 2.73 8.48% | 3.13 14.53% | 8.98 187.09% | |
receivables turnover | 7.95 - | 8.92 12.18% | 8.30 7.01% | 6.70 19.31% | 9.85 47.16% | 5.83 - | |||||
research and ddevelopement to revenue | 0.54 - | 1.25 130.31% | 1.18 5.53% | 1.31 10.51% | 0.93 28.87% | 2.13 128.73% | 2.54 19.59% | 1.22 51.93% | 0.91 25.43% | 1.78 94.72% | |
return on tangible assets | -0.17 - | -0.17 4.52% | -0.12 25.18% | -0.18 43.57% | -0.18 1.77% | -0.27 48.71% | -0.67 146.61% | -0.34 49.22% | -0.20 41.58% | -0.51 156.75% | |
revenue per share | 1.13 - | 0.41 64.12% | 0.49 20.63% | 0.53 8.28% | 0.33 38.08% | 0.43 32.14% | 0.36 17.72% | 0.43 19.59% | 1.27 198.64% | 0.25 80.69% | |
roe | -0.12 - | -0.14 23.13% | -0.12 16.39% | -0.16 30.42% | -0.16 0.75% | -0.24 53.72% | -0.54 122.67% | -0.22 59.00% | -0.22 0.99% | -0.77 241.34% | |
roic | -0.05 - | -0.11 135.46% | -0.16 43.59% | -0.15 3.24% | -0.16 5.20% | -0.22 35.84% | -0.37 70.05% | -0.18 50.94% | -0.17 5.05% | -0.62 254.44% | |
sales general and administrative to revenue | 0.17 - | 0.33 100.17% | 0.25 23.94% | 0.23 10.37% | 0.35 56.36% | 0.26 27.76% | 0.41 61.15% | 0.27 34.68% | 0.16 40.80% | ||
shareholders equity per share | 4.02 - | 5.35 33.22% | 3.94 26.43% | 4.01 1.74% | 4.54 13.25% | 3.33 26.60% | 2.16 35.04% | 1.82 15.68% | 1.51 17.38% | 0.86 43.11% | |
stock based compensation to revenue | 0.00 - | 0.02 240.51% | 0.03 105.09% | 0.01 72.66% | 0.12 1,255.55% | 0.05 62.66% | 0.08 63.51% | 0.06 17.77% | 0.01 82.00% | ||
tangible asset value | 10.69M - | 54.27M 407.53% | 42.83M 21.10% | 49.88M 16.46% | 71.20M 42.76% | 46.12M 35.22% | 21.52M 53.34% | 14.70M 31.69% | 27.28M 85.57% | 21.07M 22.78% | |
tangible book value per share | 0.88 - | 3.23 268.71% | 2.15 33.53% | 2.32 8.08% | 3.01 29.68% | 1.88 37.58% | 0.88 53.34% | 0.60 31.69% | 1.11 85.57% | 0.86 22.78% | |
working capital | 16.91M - | 50.24M 197.06% | 52.01M 3.53% | 53.53M 2.94% | 53.38M 0.30% | 47.51M 11.00% | 22.56M 52.50% | 16.13M 28.51% | 29.84M 84.97% | 10.96M 63.27% |
All numbers in EUR (except ratios and percentages)